Corvus Pharmaceuticals, Inc. CRVS Balance Sheet

Corvus pharmaceuticals, inc. (CRVS)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15
Assets
Current assets:
Cash and cash equivalents
23,498	5,154	9,067	30,183	38,976	39,196	40,747	28,068	102,565	45,106	44,104	34,095	10,487	5,050	5,576	4,343	4,065	4,105
Marketable securities
45,209	72,828	77,354	66,657	66,831	75,401	81,892	105,157	41,368	44,949	-	-	-	-	-	-	-	-
Marketable securities
-	-	-	-	-	-	-	-	-	-	55,596	76,231	111,577	129,846	139,547	147,809	148,235	90,281
Prepaid and other current assets
1,136	1,362	1,411	1,305	1,197	992	1,893	1,208	1,233	1,179	1,167	1,308	1,051	1,137	913	1,343	1,772	1,277
Total current assets
69,843	79,344	87,832	98,145	107,004	115,589	124,532	134,433	145,166	91,234	100,867	111,634	123,115	136,033	146,036	153,495	154,072	95,663
Property and equipment, net
1,278	1,462	1,642	1,824	2,010	2,180	2,226	2,293	2,459	2,672	2,863	2,984	3,117	3,248	2,858	2,807	2,552	1,845
Operating lease right-of-use asset
2,163	2,327	2,483	2,634	2,781	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	951
Other assets
513	513	513	513	514	463	464	1,193	1,064	869	1,058	869	869	869	869	619	600	-
Total assets
73,797	83,646	92,470	103,116	112,309	118,232	127,222	137,919	148,689	94,775	104,788	115,487	127,101	140,150	149,763	156,921	157,224	98,459
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
3,356	2,448	1,910	2,638	2,264	1,998	1,885	2,255	3,499	3,454	3,576	4,138	2,421	1,900	2,416	1,320	1,577	1,575
Operating lease liability
927	878	849	820	792	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued and other liabilities
7,429	6,899	6,760	7,244	5,579	5,029	5,863	7,524	7,105	5,515	6,398	5,380	5,158	4,044	3,180	2,287	1,806	1,495
Total current liabilities
11,712	10,225	9,519	10,702	8,635	7,027	7,748	9,779	10,604	8,969	9,974	9,518	7,579	5,944	5,596	3,607	3,383	3,070
Operating lease liability
2,050	2,310	2,538	2,760	2,977	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-	-	-	-	-	869	627	741	857	971	1,077	1,187	1,297	1,405	1,257	1,346	1,291	710
Total liabilities
13,762	12,535	12,057	13,462	11,612	7,896	8,375	10,520	11,461	9,940	11,051	10,705	8,876	7,349	6,853	4,953	4,674	3,780
Commitments and contingencies (Note 12)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0
Convertible preferred stock: $0.0001 par value; 0 and 14,274,741 shares authorized at December 31, 2016 and December 31, 2015, respectively; 0 and 14,274,741 issued and outstanding at December 31, 2016 and December 31, 2015, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	125,780
Stockholders' equity:
Preferred stock: $0.0001 par value; 10,000,000 shares authorized at March 31, 2020 and December 31, 2019; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0
Common stock: $0.0001 par value; 290,000,000 shares authorized at March 31, 2020 and December 31, 2019; 27,953,233 and 27,953,233 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
3	3	3	3	3	3	3	3	3	2	2	2	2	2	2	2	2	-
Additional paid-in capital
290,069	288,224	286,474	284,706	282,799	280,840	278,842	276,882	275,099	208,408	205,354	203,720	202,192	200,709	199,652	198,376	190,362	440
Accumulated other comprehensive income
43	29	34	39	11	-34	-35	-20	-39	-41	-14	-52	-62	-39	41	78	29	-45
Accumulated deficit
-230,080	-217,145	-206,098	-195,094	-182,116	-170,473	-159,963	-149,466	-137,835	-123,534	-111,605	-98,888	-83,907	-67,871	-56,785	-46,488	-37,843	-31,496
Total stockholders' equity
60,035	71,111	80,413	89,654	100,697	110,336	118,847	127,399	137,228	84,835	93,737	104,782	118,225	132,801	142,910	151,968	152,550	-31,101
Total liabilities and stockholders' equity
73,797	83,646	92,470	103,116	112,309	118,232	127,222	137,919	148,689	94,775	104,788	115,487	127,101	140,150	149,763	156,921	157,224	98,459